Lexaria Bioscience Statistics
Total Valuation
LEXX has a market cap or net worth of $22.69 million. The enterprise value is $18.18 million.
Important Dates
The next estimated earnings date is Tuesday, November 25, 2025, after market close.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LEXX has 22.24 million shares outstanding. The number of shares has increased by 62.48% in one year.
| Current Share Class | 22.24M |
| Shares Outstanding | 22.24M |
| Shares Change (YoY) | +62.48% |
| Shares Change (QoQ) | +4.49% |
| Owned by Insiders (%) | 4.97% |
| Owned by Institutions (%) | 5.10% |
| Float | 19.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.21 |
| Forward PS | 50.89 |
| PB Ratio | 3.59 |
| P/TBV Ratio | 4.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.90, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.90 |
| Quick Ratio | 3.35 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.89% and return on invested capital (ROIC) is -93.60%.
| Return on Equity (ROE) | -152.89% |
| Return on Assets (ROA) | -84.74% |
| Return on Invested Capital (ROIC) | -93.60% |
| Return on Capital Employed (ROCE) | -216.28% |
| Revenue Per Employee | $87,989 |
| Profits Per Employee | -$1.63M |
| Employee Count | 7 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.07% in the last 52 weeks. The beta is 0.80, so LEXX's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -55.07% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 55.29 |
| Average Volume (20 Days) | 293,454 |
Short Selling Information
The latest short interest is 1.00 million, so 4.50% of the outstanding shares have been sold short.
| Short Interest | 1.00M |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 4.50% |
| Short % of Float | 5.10% |
| Short Ratio (days to cover) | 0.82 |
Income Statement
In the last 12 months, LEXX had revenue of $615,923 and -$11.39 million in losses. Loss per share was -$0.67.
| Revenue | 615,923 |
| Gross Profit | 613,203 |
| Operating Income | -11.36M |
| Pretax Income | -11.40M |
| Net Income | -11.39M |
| EBITDA | -11.28M |
| EBIT | -11.36M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $4.63 million in cash and $116,586 in debt, giving a net cash position of $4.51 million or $0.20 per share.
| Cash & Cash Equivalents | 4.63M |
| Total Debt | 116,586 |
| Net Cash | 4.51M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 5.17M |
| Book Value Per Share | 0.28 |
| Working Capital | 4.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.70 million and capital expenditures -$67,659, giving a free cash flow of -$9.77 million.
| Operating Cash Flow | -9.70M |
| Capital Expenditures | -67,659 |
| Free Cash Flow | -9.77M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
| Gross Margin | 99.56% |
| Operating Margin | -1,844.66% |
| Pretax Margin | -1,851.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LEXX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.48% |
| Shareholder Yield | -62.48% |
| Earnings Yield | -50.21% |
| FCF Yield | -43.05% |
Analyst Forecast
The average price target for LEXX is $4.00, which is 292.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 292.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 158.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 12, 2021. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 12, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
LEXX has an Altman Z-Score of -3.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.01 |
| Piotroski F-Score | 3 |
